Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon!

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis.PloS one · 2021
   Pooled it
2. Microplastics and probiotics: Mechanisms of interaction and their consequences for health.AIMS microbiology · 2025
   Review
3. Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.Diagnostics (Basel, Switzerland) · 2024
   Review
4. A long journey to treat epilepsy with the gut microbiota.Frontiers in cellular neuroscience · 2024
   Review
5. Therapeutic potential of probiotics - Lactobacillus plantarum UBLP40 and Bacillus clausii UBBC07 on thioacetamide-induced acute hepatic encephalopathy in rats.Metabolic brain disease · 2022
   Article
6. Probiotics for Parkinson's Disease.International journal of molecular sciences · 2019
   Review
7. Nonpharmacological Modulation of Chronic Inflammation in Parkinson's Disease: Role of Diet Interventions.Parkinson's disease · 2019
   Review
8. Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.Current behavioral neuroscience reports · 2017
   Review
9. Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial.Evidence-based complementary and alternative medicine : eCAM · 2016
   Article
10. Brain-gut-microbiota axis in Parkinson's disease.World journal of gastroenterology · 2015
    Review
11. Microbiota-oriented strategies to mitigate parenteral nutrition-related complications in intestinal failure: A narrative review.Intestinal Failure (New York, N.Y.)
    Review

Corrections and comments

• Comment on
  Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study.2014

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as